Page last updated: 2024-08-17

methylene blue and Non-alcoholic Fatty Liver Disease

methylene blue has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castro E Silva, O; Evora, PRB; Mente, ED; Mumic, FT; Silveira, MRG; Vilalva, KH	1

Other Studies

1 other study(ies) available for methylene blue and Non-alcoholic Fatty Liver Disease

Article	Year
Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2018, Volume: 16, Issue:4 Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Liver Transplantation; Methylene Blue; Middle Aged; Non-alcoholic Fatty Liver Disease; Reperfusion Injury; Shock; Treatment Outcome; Vasoplegia	2018

Article

Year

Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2018, Volume: 16, Issue:4

Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Liver Transplantation; Methylene Blue; Middle Aged; Non-alcoholic Fatty Liver Disease; Reperfusion Injury; Shock; Treatment Outcome; Vasoplegia

2018